Ocufolin for Eye Conditions

Clinical Applications of Advanced Ophthalmic Imaging

Recruiting N/A Interventional Study
Multiple Sclerosis Dry Eye Syndromes Diabetic Retinopathy Presbyopia Myopia Dementia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
5,000 (estimated)
Sponsor
University of Miami · Other
Who this trial is looking for

This trial is looking for individuals with eye conditions such as diabetic retinopathy or multiple sclerosis to test advanced eye imaging and the effects of an over-the-counter medical food called Ocufolin over 6 months. Participants will undergo eye imaging and follow instructions related to the study.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old
  • I have clear corneas and crystalline lens
  • My initial vision is 20/80 or better
  • I have mild to moderate micro-aneurismal vascular retinopathy
  • My hemoglobin A1c is 10 or less
  • I have been diagnosed with an eye condition
  • I can follow participant instructions

You may not be able to join if

  • I have an active ocular disease
  • I have had surgery or an eye injury within the last 6 months
  • I cannot read and sign the consent form
  • I cannot tolerate bright light during imaging

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls. There are two phases in this study. The first phase is an observational phase which studies the eye in various conditions. The second phase is a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Observational Phase 1 Group Inclusion Criteria: 1. Self-reported normal healthy subjects; 2. Clinical diagnosis of Alzheimer's Disease, mild cognitive impairment, multiple sclerosis, dry eye, myopia, diabetics and stroke; 3. Who can keep the eye open for imaging. Exclusion Criteria: 1. who can n…
Contacts

Jianhua Wang, MD, PhD

3054825010

jwang3@med.miami.edu

CONTACT